Earnings — page 3
Black Rock Raises 2026 Opening Target to 40
Third-quarter revenue reached $66.8 million, up 29.7% from a year earlier, as same-store sales growth accelerated to 5.8%.
B&G Foods Restores Base Sales Growth and Lifts 2026 Outlook
Third-quarter net sales reached $459.8 million and full-year sales guidance moved to as much as $1.800 billion.
BridgeBio Oncology Extends Cash Runway Into 2029
Cash, cash equivalents and marketable securities stood at $315.3 million as of September 30, 2026, as the company reported a $34.2 million net loss for the third quarter.
Aviat Networks Updates Fiscal 2027 Revenue Outlook
The wireless transport maker booked more than $150 million in first-quarter orders, a 75% year-over-year rise, as it guided full-year revenue to $450 million to $475 million.
Ampco's Third-Quarter Sales Rise From Second Quarter
Net sales were $111.7 million as Air and Liquid Processing more than offset a U.K. plant closure in Forged and Cast products.
Zentalis Extends Cash Runway Into First Half of 2028
Cash, cash equivalents and marketable securities reached $228.9 million after an August equity raise, while the company still targets a first-half 2027 DENALI topline readout.
ZipRecruiter Raises Full-Year Outlook After Revenue Beat
Third-quarter revenue was $124.4 million, above the $118 million to $124 million range, and the company now sees 4% to 5% full-year growth.
Whitehawk Starts Third ADC Trial, Widens Quarterly Loss
Cash, cash equivalents and short-term investments stood at $169.7 million as of September 30, 2026, with the company still anticipating funding into the second half of 2028.
Village Farms Cannabis Sales Hit Record as Gross Margin Falls
Cannabis net sales reached a record $55.0 million in the third quarter, while cannabis gross margin compressed to 48% from 55% a year earlier.
Ultralife Reverses Sales Decline as Backlog Hits Record
Third-quarter sales were $48.3 million, up 11.3% from a year earlier, and backlog reached a record $136.0 million.
Tonix TONMYA Sales Reach $15 Million After Medicare Deals
TONMYA net sales were about $15 million in the third quarter, up 37% from $11 million, as covered lives reached about 166 million.
Telos Raises Full-Year Outlook After Record Quarterly Profit
Third-quarter revenue of $55.2 million exceeded guidance as GAAP net income reached $4.4 million, the highest quarterly profit since the IPO.
SIGA Completes 19C Deliveries and Posts a Third-Quarter Loss
Product sales were $0.2 million in the three months ended September 30, 2026, after $37.9 million in the second quarter.
Somnigroup Revises 2026 Adjusted EPS Outlook After Leggett Close
The bedding company posted record third-quarter net sales of $2.35 billion and set full-year adjusted EPS at $2.85–$2.95.
Superior Group Tightens 2026 Sales and Adjusted Earnings Floors
Third-quarter net sales were $146.0 million, up 5% from a year earlier, as Healthcare Apparel swung to a Segment Adjusted EBITDA loss.
Repay Cuts Full-Year Normalized Organic Growth Outlook
Third-quarter revenue reached $153.4 million as Consumer Payments organic growth stalled and the company lowered normalized organic growth to 5%-6%.
Ranger Energy's Sequential Revenue Growth Reverses
Third-quarter revenue was $162.8 million and Adjusted EBITDA $20.1 million as activity and costs compressed earnings.
Quanterix Narrows 2026 Revenue Outlook After Sequential Gain
Third-quarter revenue was $35.0 million, up 6.3% from the second quarter, reversing a drop from $36.4 million in the first quarter.
Quantum Extends Sequential Sales Streak and Non-GAAP Profit
Fiscal second-quarter revenue reached $89.6 million, up 42.9% from a year earlier, as the company posted a second straight quarter of non-GAAP profit.
OraSure Reverses Two-Quarter Revenue Decline
Third-quarter net revenues reached $30.9 million, up 14% from a year earlier, as the company guided a faster 2027 growth pace.
Octave Specialty Group's Third-Quarter Loss Narrows
Adjusted EBITDA to shareholders was $3.3 million, and Insurance Distribution revenue rose 35% to $58.4 million.
OPAL Fuels Flags 2026 RNG Output Below Guidance
Third-quarter Adjusted EBITDA reached $26.7 million as the company said full-year results should sit at the lower end of its range.
Microvast Flags Going-Concern Doubt After Sales Collapse
Third-quarter revenue fell to $45.8 million and the company said cash is expected to be insufficient for the next twelve months absent financing or debt relief.
Motorcar Parts Cuts Fiscal Sales Outlook After Order Delays
The aftermarket parts maker now sees fiscal 2027 net sales of $715 million to $740 million after second-quarter sales of $169.2 million.
Lantronix Non-GAAP Profit Rises 50% Alongside Embedded IoT
Net revenue reached $32.4 million in the fiscal first quarter as Embedded IoT Solutions hit $15.7 million and the company reaffirmed double-digit growth for fiscal 2027.
LifeVantage Posts First Net Loss in Two Quarters
Revenue fell 22.0% to $37.1 million in the quarter ended September 30, 2026, and the company swung to a $0.02 a share net loss.
LoanDepot's Origination Volume Falls After a Second-Quarter Rebound
The lender booked a $29 million net loss as pull-through weighted gain on sale margin reached 399 basis points.
Kaltura Reports 8% Revenue Growth in Third Quarter 2026
Third-quarter revenue of $47.3 million exceeded the high end of guidance as the company forecast full-year total revenue of $185.0 million–$185.7 million.
KKR Extends Record Earnings Streak and Lifts Buyback
Fee Related Earnings rose 27% to $1.3 billion, or $1.42 a share, as the firm posted a second straight quarter of record FRE, TOE and ANI per share.
James River Swings to a Third-Quarter Operating Loss
A $19.2 million E&S reserve add and a $181.8 million goodwill write-off produced a $4.08 a share net loss and a $4.4 million adjusted operating loss.
ImmunityBio's Sequential ANKTIVA Revenue Streak Ends
Third-quarter net product revenue was $48.7 million, up 53% from a year earlier, as the FDA expanded the ANKTIVA label and the company met a BCG-naïve trial endpoint.
Greystone Housing Impact Investors Posts Third-Quarter Profit
Cash available for distribution was $3.8 million, or $0.17 a BUC, as the partnership sold Vantage at Loveland for about $23.6 million.
Foghorn Records $58.2 Million Profit After Dropping FHD-909
Collaboration revenue reached $83.5 million in the third quarter, including a $74.1 million catch-up primarily related to updated estimated future costs for decisions not to advance FHD-909 and the SMARCA2 selective degrader; earnings were $0.81 a share.
FutureFuel Restores Biodiesel Run-Rate After Chemical Turnarounds
Third-quarter revenue reached $104.7 million as the company guided fourth-quarter Adjusted EBITDA to about $7 million.
Ferguson Raises 2026 Sales Outlook After FloWorks Close
Third-quarter sales reached $9.03 billion, up 9.5%, as organic growth accelerated and the company lifted full-year net sales guidance to about 7%.
EVI's Operating Income Reaches a Record $6.2 Million
Commercial laundry operating income rose 38% to $11.3 million as the company posted record first-fiscal-quarter results and closed a consumer garment care deal.
Claritev Raises 2026 Outlook and Flags $1.1 Billion 2027
Third-quarter revenue reached $268.3 million as the company lifted full-year sales guidance to $1.038 billion–$1.043 billion.
CNH Raises 2026 Outlook After Kobelco Construction Deal
Adjusted net income reached $205 million in the third quarter as the company lifted full-year adjusted diluted EPS to $0.44–$0.48.
Compass Third-Quarter Net Loss Widens to $27.2 Million
Third-quarter 2026 research and development expenses rose 72% to $22.0 million as net loss widened to $27.2 million. Cash and marketable securities were $163 million at September 30, 2026, which the company said is expected to fund operations into 2028.
Coherus Cuts Headcount 30% to Focus on Esophageal Cancer
LOQTORZI net revenue reached $14.0 million in the third quarter as the company narrowed its tagmokitug program and lowered the LOQTORZI sales needed to cover core cash burn.
Constellation Raises Full-Year Earnings Outlook Again
Adjusted operating earnings reached $5.06 a share in the third quarter, and the company lifted its 2026 range to $12.50–$12.80 a share.
Crescent Capital BDC Restores Net Income After Two Loss Quarters
Net investment income was $0.37 a share, and the board authorized a $50 million share repurchase.
Perspective Extends Cash Runway Into 2028
Cash, cash equivalents, and short-term investments were about $202 million as of September 30, 2026, and the company said the balance should fund planned clinical work into 2028.
Berkshire Operating Earnings Slip as Underwriting Falls
Third-quarter operating earnings were $12.71 billion, with insurance underwriting at $1.35 billion and net earnings of $22.11 billion.
Bakkt Sets First-Half 2027 Volume Target of $6 Billion
Third-quarter Total Transacting Volume was $147.9 million as Bakkt reiterated a $3 billion full-year 2026 TTV goal and reported net income of $14.3 million.
AN2 Therapeutics Clears Global Phase 2 Epetraborole Study
Cash, cash equivalents and investments were $80.2 million as of September 30, 2026, and the company said it expects to start polycythemia vera enrollment by year-end.
Alta Narrows 2026 EBITDA Outlook After Third-Quarter Loss
The equipment dealer posted a $12.2 million net loss, or $0.37 a share, and now sees 2026 Adjusted EBITDA of $165.0 million to $170.0 million.
ADC Therapeutics Completes $86.6 Million PIPE After Third-Quarter Loss
Net product revenue was $21.0 million and cash stood at $189.2 million as of September 30, 2026, with an expected runway into 2029.
Abeona Narrows Loss as ZEVASKYN Treatments Rise
Net ZEVASKYN revenue was $13.5 million in the third quarter, and the company completed six treatments as its qualified-center network reached eight sites.
Rabobank net interest income rises 10% as profit holds
Net interest income reached EUR 6,448 million in the first half of 2026 as net profit stayed at EUR 2,694 million.